Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small molecules in an RNAi world.

Ulrike S Eggert1, Christine M Field, Timothy J Mitchison

  • 1Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA. ulrike_eggert@hms.harvard.edu

Molecular Biosystems
|August 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rebinding drives cellular retention of small-molecule drugs with abundant targets.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Lipid-trap mass spectrometry identifies lipid-protein interactions in cells.

Nature cell biology·2026
Same author

Structure-based discovery of selective vaccinia-related kinase 1 inhibitors and fluorogenic active-site probes.

The Journal of biological chemistry·2026
Same author

Spatial control of Keratin 8 phosphorylation by Aurora B facilitates cytokinesis in cancer cells of epithelial origin.

The FEBS journal·2026
Same author

An abundant membrane protein in the NCAM superfamily is required for epithelial organization in sea anemone embryos.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Dynamic microtubules as sensors in animal cells.

Biophysical journal·2025
Same journal

Imbalance in amino acid and purine metabolisms at the hypothalamus in inflammation-associated depression by GC-MS.

Molecular bioSystems·2017
Same journal

Correction: Dynamic properties of dipeptidyl peptidase III from Bacteroides thetaiotaomicron and the structural basis for its substrate specificity - a computational study.

Molecular bioSystems·2017
Same journal

Conformational heterogeneity in tails of DNA-binding proteins is augmented by proline containing repeats.

Molecular bioSystems·2017
Same journal

Mechanism of the formation of the RecA-ssDNA nucleoprotein filament structure: a coarse-grained approach.

Molecular bioSystems·2017
Same journal

Staphylococcus aureus extracellular vesicles (EVs): surface-binding antagonists of biofilm formation.

Molecular bioSystems·2017
Same journal

Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases.

Molecular bioSystems·2017
See all related articles

This opinion piece compares small molecules and RNA interference (RNAi) therapeutics, evaluating their pros and cons for timing, specificity, dosage, and clinical applications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Small molecules and RNA interference (RNAi) are key therapeutic modalities.
  • Both approaches offer distinct mechanisms for modulating gene and protein expression.

Purpose of the Study:

  • To compare and contrast small molecule drugs and RNAi technologies.
  • To analyze the advantages and disadvantages of each therapeutic strategy.

Main Methods:

  • Comparative analysis of small molecule and RNAi platforms.
  • Evaluation based on critical parameters including timing, specificity, and dosage.

Main Results:

  • Small molecules offer broad applicability but can have off-target effects.

Related Experiment Videos

  • RNAi provides high specificity but faces challenges in delivery and stability.

    • Conclusions:

    • The choice between small molecules and RNAi depends on specific therapeutic goals.
    • Optimizing timing, specificity, and dose is crucial for successful clinical translation of both technologies.